Differentiating profiles of speech impairments in Friedreich's ataxia: a perceptual and instrumental approach

International Journal of Language & Communication Disorders. doi: 10.1111/j.1460-6984.2011.00078.x

Folker, J. E., Murdoch, B. E., Rosen, K. M., Cahill, L. M., Delatycki, M. B., Corben, L. A. and Vogel, A. P.

Keywords: dysarthria, neurodegenerative diseases, motor speech disorders, Friedreich's ataxia (FRDA), speech sample using an interval rating scale, instrumental measures, respiratory, laryngeal, velopharyngeal, articulatory systems.

Efficacy Study of Epoetin Alfa in Friedreich Ataxia (FRIEMAX)

ClinicalTrials.gov Identifier: NCT01493973

Sponsor: Federico II University

Collaborators: Friedreich's Ataxia Research Alliance (FARA)
Associazione Italiana per la lotta alle Sindromi Atassiche (AISA)

Information provided by (Responsible Party): Alessandro Filla, Federico II University

"This study is not yet open for participant recruitment."

Pharmacodynamic studies of a histone deacetylase inhibitor in Friedreich’s ataxia

EU Clinical Trials Register

EudraCT Number: 2011-002744-27
Sponsor's Protocol Code Number: CR01849
National Competent Authority: UK - MHRA
Clinical Trial Type: EEA CTA
Trial Status: Ongoing
Date on which this record was first entered in the EudraCT database: 2011-09-16

Ataxia UK, Lay summary of Festenstein's hdaci study